167 related articles for article (PubMed ID: 16410727)
21. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
Phelps DE; Xiong Y
Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
[TBL] [Abstract][Full Text] [Related]
22. Negative regulation of TSC1-TSC2 by mammalian D-type cyclins.
Zacharek SJ; Xiong Y; Shumway SD
Cancer Res; 2005 Dec; 65(24):11354-60. PubMed ID: 16357142
[TBL] [Abstract][Full Text] [Related]
23. NMR and mass spectrometry studies of putative interactions of cell cycle proteins pRb and CDK6 with cell differentiation proteins MyoD and ID-2.
Smialowski P; Singh M; Mikolajka A; Majumdar S; Joy JK; Nalabothula N; Krajewski M; Degenkolbe R; Bernard HU; Holak TA
Biochim Biophys Acta; 2005 Jun; 1750(1):48-60. PubMed ID: 15878699
[TBL] [Abstract][Full Text] [Related]
24. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event.
Zancai P; Cariati R; Rizzo S; Boiocchi M; Dolcetti R
Oncogene; 1998 Oct; 17(14):1827-36. PubMed ID: 9778049
[TBL] [Abstract][Full Text] [Related]
25. Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6.
Morse L; Chen D; Franklin D; Xiong Y; Chen-Kiang S
Immunity; 1997 Jan; 6(1):47-56. PubMed ID: 9052836
[TBL] [Abstract][Full Text] [Related]
26. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.
Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L
J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693
[TBL] [Abstract][Full Text] [Related]
27. Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro.
Takaki T; Fukasawa K; Suzuki-Takahashi I; Semba K; Kitagawa M; Taya Y; Hirai H
J Biochem; 2005 Mar; 137(3):381-6. PubMed ID: 15809340
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A.
Fåhraeus R; Paramio JM; Ball KL; Laín S; Lane DP
Curr Biol; 1996 Jan; 6(1):84-91. PubMed ID: 8805225
[TBL] [Abstract][Full Text] [Related]
29. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors.
Parry D; Mahony D; Wills K; Lees E
Mol Cell Biol; 1999 Mar; 19(3):1775-83. PubMed ID: 10022865
[TBL] [Abstract][Full Text] [Related]
30. Cyclic AMP-dependent phosphorylation of cyclin D3-bound CDK4 determines the passage through the cell cycle restriction point in thyroid epithelial cells.
Paternot S; Coulonval K; Dumont JE; Roger PP
J Biol Chem; 2003 Jul; 278(29):26533-40. PubMed ID: 12730225
[TBL] [Abstract][Full Text] [Related]
31. Bisphenol S promotes the cell cycle progression and cell proliferation through ERα-cyclin D-CDK4/6-pRb pathway in MCF-7 breast cancer cells.
Lin Z; Zhang X; Zhao F; Ru S
Toxicol Appl Pharmacol; 2019 Mar; 366():75-82. PubMed ID: 30684532
[TBL] [Abstract][Full Text] [Related]
32. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks.
Upton JW; van Dyk LF; Speck SH
Virology; 2005 Oct; 341(2):271-83. PubMed ID: 16102793
[TBL] [Abstract][Full Text] [Related]
33. CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation.
Tigan AS; Bellutti F; Kollmann K; Tebb G; Sexl V
Oncogene; 2016 Jun; 35(24):3083-91. PubMed ID: 26500059
[TBL] [Abstract][Full Text] [Related]
34. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts.
Stein GH; Drullinger LF; Soulard A; Dulić V
Mol Cell Biol; 1999 Mar; 19(3):2109-17. PubMed ID: 10022898
[TBL] [Abstract][Full Text] [Related]
35. Attenuation of the retinoblastoma pathway in pancreatic neuroendocrine tumors due to increased cdk4/cdk6.
Tang LH; Contractor T; Clausen R; Klimstra DS; Du YC; Allen PJ; Brennan MF; Levine AJ; Harris CR
Clin Cancer Res; 2012 Sep; 18(17):4612-20. PubMed ID: 22761470
[TBL] [Abstract][Full Text] [Related]
36. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
Santamaria D; Ortega S
Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
[TBL] [Abstract][Full Text] [Related]
37. Cyclin D-CDK4/6 functions in cancer.
Gao X; Leone GW; Wang H
Adv Cancer Res; 2020; 148():147-169. PubMed ID: 32723562
[TBL] [Abstract][Full Text] [Related]
38. Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins.
Lasorella A; Iavarone A; Israel MA
Mol Cell Biol; 1996 Jun; 16(6):2570-8. PubMed ID: 8649364
[TBL] [Abstract][Full Text] [Related]
39. The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival.
Wang H; Nicolay BN; Chick JM; Gao X; Geng Y; Ren H; Gao H; Yang G; Williams JA; Suski JM; Keibler MA; Sicinska E; Gerdemann U; Haining WN; Roberts TM; Polyak K; Gygi SP; Dyson NJ; Sicinski P
Nature; 2017 Jun; 546(7658):426-430. PubMed ID: 28607489
[TBL] [Abstract][Full Text] [Related]
40. Cdk2-dependent phosphorylation and functional inactivation of the pRB-related p130 protein in pRB(-), p16INK4A(+) tumor cells.
Cheng L; Rossi F; Fang W; Mori T; Cobrinik D
J Biol Chem; 2000 Sep; 275(39):30317-25. PubMed ID: 10906146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
